Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.370
+0.060 (4.58%)
At close: Dec 31, 2025, 4:00 PM EST
1.310
-0.060 (-4.38%)
After-hours: Dec 31, 2025, 7:38 PM EST
Allogene Therapeutics Market Cap
Allogene Therapeutics has a market cap or net worth of $307.88 million as of December 31, 2025. Its market cap has decreased by -22.31% in one year.
Market Cap
307.88M
Enterprise Value
140.83M
1-Year Change
-22.31%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $307.88M, a decrease of -89.31%. That is a compound annual growth rate of -26.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 307.88M | -31.06% |
| Dec 31, 2024 | 446.60M | -17.32% |
| Dec 29, 2023 | 540.17M | -40.45% |
| Dec 30, 2022 | 907.08M | -57.34% |
| Dec 31, 2021 | 2.13B | -39.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |